P Rutecki
Overview
Explore the profile of P Rutecki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hermann B, Seidenberg M, Sears L, Hansen R, Bayless K, Rutecki P, et al.
Neurology
. 2004 Dec;
63(11):2129-31.
PMID: 15596761
The authors examined a cognitive function mediated by the cerebellum, classical eyeblink conditioning, and its relationship to cerebellar volume in healthy controls (n = 59) and temporal lobe epilepsy subjects...
2.
Oyegbile T, Dow C, Jones J, Bell B, Rutecki P, Sheth R, et al.
Neurology
. 2004 May;
62(10):1736-42.
PMID: 15159470
Objective: To characterize the nature and degree of cognitive morbidity in patients with chronic temporal lobe epilepsy compared with healthy control subjects, determine the association between the duration of epilepsy...
3.
Collins M, Marin H, Rutecki P, Heller D
J Am Med Dir Assoc
. 2003 Jun;
2(2):66-70.
PMID: 12812592
Introduction: A growing population of residents in long-term care facilities (LTCF) is likely to present with status epilepticus (SE), which requires rapid treatment to avoid permanent neuronal damage, associated morbidity,...
4.
Hermann B, Seidenberg M, Bell B, Woodard A, Rutecki P, Sheth R
Epilepsy Behav
. 2003 Mar;
1(3):184-90.
PMID: 12609152
Purpose. The goals of this work were to determine: (1) the nature and extent of differences in self-reported psychiatric symptoms between patients with temporal lobe epilepsy and matched healthy controls,...
5.
Gidal B, Radulovic L, Kruger S, Rutecki P, Pitterle M, Bockbrader H
Epilepsy Res
. 2000 Jun;
40(2-3):123-7.
PMID: 10863139
Unlabelled: Gabapentin (GBP) is a non-metabolized, non-plasma protein bound, renally excreted antiepileptic drug that is actively absorbed via the system L amino acid transporter. Previous studies have demonstrated that gabapentin...
6.
Gidal B, Walker J, Lott R, Shaw R, Speth J, Marty K, et al.
Seizure
. 2000 Jun;
9(2):131-6.
PMID: 10845738
The paper evaluates the efficacy of the newer anticonvulsant lamotrigine in a developmentally disabled patient population. A retrospective evaluation was done at two institutional centres to assess adjunctive lamotrigine (Lamictal)...
7.
Gidal B, Seltz J, Rutecki P
Semin Pediatr Neurol
. 1999 Oct;
6(3):146-9; discussion 149-50.
PMID: 10522330
A 13-year-old boy with Lennox-Gastaut syndrome characterized by absence, myoclonic, complex-partial, and secondarily generalized tonic-clonic seizures, presents with progressive obtundation and loss of motor and verbal skills over a 2-day...
8.
Sayin , Rutecki P, Sutula T
J Neurophysiol
. 1999 Feb;
81(2):564-74.
PMID: 10036260
Single-electrode voltage-clamp techniques and bath application of the N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-5-phosphonovaleric acid (APV) were used to study the time course of seizure-induced alterations in NMDA-dependent synaptic currents in...
9.
Gidal B, DeCerce J, Bockbrader H, Gonzalez J, Kruger S, Pitterle M, et al.
Epilepsy Res
. 1998 Aug;
31(2):91-9.
PMID: 9714500
Unlabelled: Gabapentin (GBP) is a non-metabolized antiepileptic drug that is eliminated by renal excretion and displays saturable, dose dependent absorption. The recommended dosing schedule for GBP is t.i.d. At large...
10.
Gidal B, Rutecki P, Shaw R, Maly M, Collins D, Pitterle M
Epilepsy Res
. 1997 Oct;
28(3):207-11.
PMID: 9332885
Although lamotrigine (LTG) appears to have a low propensity to cause pharmacokinetic interactions with other medications, it has been suggested that LTG may interfere with the elimination of carbamazepine 10,11-epoxide...